Alizé Pharma Investors

29 investors on Angel Roster list Alizé Pharma in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States, France and Israel.

Investors are matched on the company name in their portfolio, so companies that share the name Alizé Pharma can appear together.

Investors listed
29
With verified email
34%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 29 Alizé Pharma investors

The most complete profiles first. Showing 29 of 29.

  • David BonitaVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 93 more

    Verified email available

  • Geoffrey HsuVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Meredith FisherVerified

    Venture Capital, Investor · United States

    SeedHealth CareWellnessWomen FoundedLife Science

    Portfolio: CoStim Pharmaceuticals, Magenta Therapeutics, ImmuneXcite, InStore Finance and 23 more

    Verified email available

  • Philippe PeltierVerified

    Venture Capital, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: Implanet, AM Pharma, FeetMe, Advanced Perfusion Diagnostics and 36 more

    Verified email available

  • Roger KittermanVerified

    Venture Capital, Investor · United States

    SeedHealth CareWellnessWomen FoundedLife Science

    Portfolio: CoStim Pharmaceuticals, Magenta Therapeutics, ImmuneXcite, InStore Finance and 23 more

    Verified email available

  • Thierry LaugelVerified

    Venture Capital, Private Equity Firm, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Verified email available

  • Vanessa MalierVerified

    Venture Capital, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Verified email available

  • Jonathan SilversteinVerified

    Private Equity Firm · United States

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Jonathan WangVerified

    Private Equity Firm · China

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Rishi GuptaVerified

    Private Equity Firm · United States

    Health CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Amine MAROUF

    Venture Capital, Private Equity Firm, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Contact details available

  • Carl Berke

    Venture Capital, Investor · United States

    SeedHealth CareWellnessWomen FoundedLife Science

    Portfolio: CoStim Pharmaceuticals, Magenta Therapeutics, ImmuneXcite, InStore Finance and 23 more

    Contact details available

  • Carter Neild

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Chau Khuong

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Gennao Bio, Yisheng Biopharma and 89 more

    Contact details available

  • Drew Burdon

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    Series BHealth CareLife ScienceMobileManufacturing

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Hadrien Bouchez

    Venture Capital, Private Equity Firm, Investor · Netherlands

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Contact details available

  • Martijn Kleijwegt

    Venture Capital, Private Equity Firm, Investor · Netherlands

    Series BHealth CareLife ScienceMobileManufacturing

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Ran Nussbaum

    Venture Capital, Founder, Private Equity Firm · Israel

    Series BHealth CareLife ScienceInformation Technology (IT)Manufacturing

    Portfolio: Rewalk Robotics, VBI Vaccines, CathWorks, ProtAb and 48 more

    Contact details available

  • Rudy Dekeyser

    Venture Capital, Private Equity Firm, Investor · Belgium

    Series BHealth CareHospitalsLife ScienceMobile

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Scotland Stevens

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Sylvain Cascarino

    Venture Capital, Private Equity Firm, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Contact details available

  • Vincent Brichard

    Private Equity Firm, Investor · Netherlands

    SeedHealth CareLife ScienceMobileManufacturing

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • ohad hammer

    Venture Capital, Scout, Private Equity Firm · Israel

    Series BHealth CareLife ScienceInformation Technology (IT)Manufacturing

    Portfolio: Rewalk Robotics, VBI Vaccines, CathWorks, ProtAb and 48 more

    Contact details available

  • Anat Naschitz

    Private Equity Firm · Israel

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Erez Chimovits

    Private Equity Firm · Israel

    Health CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Julius Knowles

    Venture Capital, Design Operator, Strategy Operator · United States

    Health CareHospitalsWellnessWomen Founded

    Portfolio: CoStim Pharmaceuticals, Magenta Therapeutics, ImmuneXcite, InStore Finance and 23 more

    Contact details available

  • Merijn Klaassen

    Private Equity Firm · Netherlands

    Health CareLife ScienceMobileManufacturing

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Peter Neubeck

    Venture Capital, Private Equity Firm · Germany

    Health CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Contact details available

  • Ruoxi Hu

    Venture Capital · United States

    Health CareWellnessWomen FoundedLife Science

    Portfolio: CoStim Pharmaceuticals, Magenta Therapeutics, ImmuneXcite, InStore Finance and 23 more

    Contact details available

Frequently asked questions

How many Alizé Pharma investors are on Angel Roster?

Angel Roster lists 29 Alizé Pharma investors. 10 of them (34%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (22), Private Equity Firms (22) and VC Scouts (1). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Alizé Pharma investors invest in?

Among those that list a stage, the most common are Seed (15), Series A (5) and Series B (5).

Where are Alizé Pharma investors based?

Most are based in the United States (12), France (5) and Israel (4).

Which companies have Alizé Pharma investors backed?

The most-backed portfolio companies among them are Keros Therapeutics (17), Vico Therapeutics (14), AM Pharma (12), OxThera (12) and Adicet Bio (12).

How do I contact Alizé Pharma investors?

Create a free Angel Roster account to search and filter all 29, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.